Nationwide Fund Advisors Abb Vie Inc. Transaction History

Nationwide Fund Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 01, 2018	SELL	$89.56 - $98.21 $45.7 Million - $50.1 Million	-510,438 Closed	0 $0
Q3 2017 Oct 23, 2017	SELL	$69.85 - $89.22 $1.15 Million - $1.47 Million	-16,482 Reduced 3.13%	510,438 $45.4 Million
Q2 2017 Aug 10, 2017	BUY	N/A	526,920	526,920 $38.2 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Nationwide Fund Advisors, based on Form 13F filings with the SEC.

Stay updated on Nationwide Fund Advisors with notifications on news.